Effect of FK506 on functional recovery after facial nerve injury in the rat

Archives of Facial Plastic Surgery

Volumn 9, Issue 5, 2007, Pages 333-339

  Yeh, Cory ^a   Bowers, Daniel ^a   Hadlock, Tessa A ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ANIMAL; ARTICLE; BLINKING; CONVALESCENCE; DRUG EFFECT; FACIAL NERVE INJURY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLINKING; FACIAL NERVE INJURIES; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAMUSCULAR; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TACROLIMUS;

EID: 34848872512     PISSN: 15212491     EISSN: 15383660     Source Type: Journal    
DOI: 10.1001/archfaci.9.5.333     Document Type: Article

References (25)

1. Cheney M. Facial Surgery: Plastic and Reconstructive. Baltimore, MD: Williams & Wilkins; 1997.
2. Ferri CC, Moore F, Bisby M. Effects of facial nerve injury on mouse motoneurons lacking the p75 low-affinity neurotrophin receptor. J Neurobiol. 1998;34(1):1-9.
3. Most SP. Facial nerve recovery in bcl2 overexpression mice after crush injury. Arch Facial Plast Surg. 2004;6(2):82-87.
4. Kobayashi S, Koyama J, Yokouchi K, Fukushima N, Oikawa S, Moriizumi T. Functionally essential neuronal population of the facial motor nucleus. Neurosci Res. 2003;45(3):357-361.
5. Serpe CJ, Tetzlaff J, Coers S, Sanders V, Jones K. Functional recovery after facial nerve crush is delayed in severe combined immunodeficient mice. Brain Behav Immun. 2002;16(6):808-812.
6. Hadlock TA, Heaton J, Cheney M, Mackinnon S. Functional recovery after facial and sciatic nerve crush injury in the rat. Arch Facial Plast Surg. 2005;7(1):17-20.
7. Guo X, Dawson VL, Dawson TM. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. Eur J Neurosci. 2001;13(9):1683-1693.
8. Butcher SP, Henshall DC, Teramura Y, Iwasaki K, Sharkey J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J Neurosci. 1997;17(18):6939-6946.
9. Lyons WE, George EB, Dawson TM, Steiner JP, Snyder SH. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc Natl Acad Sci U S A. 1994;91(8):3191-3195.
10. Madsen JR, MacDonald P, Irwin N, et al. Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp Neurol. 1998;154(2):673-683.
11. Lee M, Doolabh VB, Mackinnon SE, Jost SC. FK506 promotes functional recovery in crushed rat sciatic nerve. Muscle Nerve. 2000;23(4):633-640.
12. Jost SC, Doolabh VB, Mackinnon SE, Lee M, Hunter D. Acceleration of peripheral nerve regeneration following FK506 administration. Restor Neurol Neurosci. 2000;17(1):39-44.
13. Feng FY, Ogden MA, Myckatyn TM, et al. FK506 rescues peripheral nerve allografts in acute rejection. J Neurotrauma. 2001;18(2):217-229.
14. Jensen JN, Brenner MJ, Tung TH, Hunter DH, Mackinnon SE. Effect of FK506 on peripheral nerve regeneration through long grafts in inbred swine. Ann Plast Surg. 2005;54(4):420-427.
15. Diaz LM, Steele MH, Guerra AB, et al. The role of topically administered FK506 (tacrolimus) at the time of facial nerve repair using entubulation neurorrhaphy in a rabbit model. Ann Plast Surg. 2004;52(4):407-413.
16. Hontanilla B, Auba C, Arcocha J, Gorria O. Nerve regeneration through nerve autografts and cold preserved allografts using tacrolimus (FK506) in a facial paralysis model: a topographical and neurophysiological study in monkeys. Neurosurgery. 2006;58(4):768-779.
17. Fernandez E, Pallini R, Marchese E, Lauretti L, LaMarca F. Quantitative, morphological, and somatotopic nuclear changes after facial nerve regeneration in adult rats: a possible challenge to the "no new neurons" dogma. Neurosurgery. 1995;37(3):456-463.
18. Streppel M, Angelov D, Guntinas-Lichius O, et al. Slow axonal regrowth but extreme hyperinnervation of target muscle after suture of the facial nerve in adult rats. Neurobiol Aging. 1998;19(1):83-88.
19. Gold BG, Katoh K, Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J Neurosci. 1995;15(11):7509-7516.
20. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today. 1992;13(4):136-142.
21. Dawson TM, Steiner JP, Dawson VL, Dinerman J, Uhl G, Snyder SH. Immuno-suppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci U S A. 1993;90(21):9808-9812.
22. Wang HG, Pathan N, Ethell I, et al. Ca2+ induced apoptosis through calcineurin dephosphorylation of BAD. Science. 1999;284(5412):339-343.
23. Gold BG, Densmore V, Shou W, Matzuk MM, Gordon HS. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J Pharmacol Exp Ther. 1999;289(3):1202- 1210.
24. Adour KK, Klein JC, Bell DN. Trigeminal neurotization of the paralyzed facial musculature: modification of the Lexer-Rosenthal surgical procedure. Arch Otolaryngol. 1979;105(1):13-16.
25. Gasser RF. The development of the facial nerve in man. Ann Otol Rhinol Laryngol. 1967;76(1):37-56.